Dr. Julio Montaner profiled in BIV’s LifeSciences magazine

Business in Vancouver’sLifesciencesmagazine recently profiled BC-CfE Executive Director & Physician-in-Chief Dr. Julio Montaner. In the profile, the history of Dr. Montaner’s career is traced from his arrival in Vancouver from Argentina in the 1980s, to the creation of Highly Active Antiretroviral Therapy (HAART), up to the global spread of the cost-saving strategy of Treatment as Prevention¨ (TasP¨) .

Read More »
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below